What Shall We Bake Today?

Food 1 Minute

Continuing on with great picnic desserts, today’s offering is Peach bars!

Ingredients

3 cups all-purpose flour

1-1/2 cups sugar, divided

1 teaspoon baking powder

1/2 teaspoon salt

Dash ground cinnamon

1 cup shortening

1 large egg

1 teaspoon vanilla extract

3 pounds peaches, peeled and chopped

1 teaspoon almond extract

4 teaspoons cornstarch

Directions

Preheat oven to 375°. Whisk flour, 1 cup sugar, baking powder, salt and cinnamon; cut in shortening until crumbly. In another bowl, whisk egg and vanilla until blended; add to flour mixture, stirring with a fork until crumbly.

Reserve 2-1/2 cups crumb mixture for topping. Press remaining mixture onto bottom of a greased 13×9-in. baking pan.

Toss peaches with almond extract. In another bowl, mix cornstarch and remaining sugar; add to peaches and toss to coat. Spread over crust; sprinkle with reserved topping.

Bake until lightly browned and filling is bubbly, 40-45 minutes. Cool completely in pan on a wire rack. Cut into bars.

Enjoy!

Unknown's avatar

Published by pat frederick

Published

105 thoughts on “What Shall We Bake Today?”

  3. Just The News: “Gislaine Maxwell’s attorney, David Oscar Markus, on Friday indicated to reporters that he was hoping President Donald Trump would pardon his client as she cooperates with the Justice Department.

    Trump has already said that he hadn’t considered a pardon for Maxwell, who was an associate and friend of the late financier Jeffrey Epstein, but he has not ruled it out permanently. 

    Markus confirmed that no pardon had been offered or discussed so far, but said “We hope [the president] exercises that power in the right and just way.”

    Liked by 1 person

  9. EXCERPT: “Rep. Paul Gosar (R-Ariz.) on Tuesday reintroduced legislation to end the liability shield for vaccine manufacturers and allow people injured by a vaccine to sue the drug’s manufacturer. Children’s Health Defense (CHD) is one of the bill’s supporters.

    The End the Vaccine Carveout Act targets two federal laws that give legal immunity to vaccine makers — the National Childhood Vaccine Injury Act of 1986 (NCVIA) and the Public Readiness and Emergency Preparedness Act of 2005 (PREP Act). The NCVIA’s liability shield covers vaccines recommended by the Centers for Disease Control and Prevention (CDC) for routine use in children or pregnant women.

    The PREP Act protects manufacturers from liability for injuries or death caused by vaccines or other countermeasures implemented during a public health emergency.

    “Current immunity provisions unfairly shielding Big Pharma from the harms caused by their products prevent those injured by vaccines to pursue a civil lawsuit in state or federal court,” Gosar said in the press release. Gosar’s bill removes language in the NCVIA that requires people injured by vaccines to first seek compensation through the government-run National Vaccine Injury Compensation Program (VICP).

    Under the new legislation, the vaccine-injured could file lawsuits against vaccine manufacturers while also submitting a VICP claim. In a press release, Gosar’s office said the VICP sets an unreasonably high bar for claimants to meet:

    “The plaintiff must prove that the vaccine manufacturer deliberately ‘[withheld] information relating to the safety or efficacy of the vaccine,’ engaged in ‘criminal or illegal activity relating to the safety and effectiveness of vaccines,’ or ‘by clear and convincing evidence … failed to exercise due care.’ “Satisfying these requirements is practically an impossibility.”

    The issue of holding vaccine makers legally accountable for injuries caused by their products came up last week, during a U.S. Senate hearing on vaccine injuries. Sen. Richard Blumenthal (D-Conn.), a staunch vaccine supporter, suggested it was time to revisit the liability issue, as did Sen. Bernie Moreno (R-Ohio), who told witnesses that when it comes to the drug industry, “The government has decided that this particular industry gets a free pass.”….”

    https://childrenshealthdefense.org/defender/rep-gosar-reintroduces-bill-strip-liability-protection-vaccine-makers/

    Liked by 1 person

  10. “Tech Billionaires Spearhead Efforts to Build Gene-Edited Designer Babies—Bootstrap Bio, a company created about 18 months ago, has “hired a chief science officer, opened a lab and pivoted its work” to genetic editing of human embryos, Bloomberg reported. In June, MIT Technology Review reported that the founder of Coinbase, whose worth is estimated at $10 billion, posted on X that he is “ready to fund a US startup focused on gene-editing human embryos.”

    by GMWatch, July 25, 2025

    baby feet

    EXCERPT: “Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.

    Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty.

    Support for keeping it legally off limits is widespread, including among scientists working to develop gene therapies. A number of key opponents and skeptics are taking new steps to make their voices heard.

    In May, the Global Observatory on Human Genome Editing, a university-based center, organized an international summit on human genome editing. Unlike the previous three summits sponsored by national science academies, its considerations of heritable editing focused on the eugenic implications and other societal risks it would entail.

    Soon after, three scientific and biotech industry organizations devoted to cell and gene therapies issued a joint call for a 10-year global ban on heritable genome editing, citing safety concerns, lack of medical need, and social and ethical risks.

    While a good number of biotech companies and organizations have consistently opposed heritable genome editing, a new joint statement by industry groups that represent thousands of scientists and major biotech companies is a significant development.

    These developments bespeak the strength of the case against heritable genome editing. But advocates of heritable genome editing who command enormous financial resources are moving ahead with no regard for its safety, societal, or eugenic risks.

    Tech billionaires and designer babies

    This week, Bloomberg News reports that Bootstrap Bio, a company created about 18 months ago, has “hired a chief science officer, opened a lab and pivoted its work” to genetic editing of human embryos. Based on investor information, it says that Bootstrap Bio may be planning to launch human trials — that is, using altered embryos to initiate pregnancies — in 2026 or 2027 in Honduras, “a place where the company could potentially avoid US regulations.”

    Bloomberg was unable to get comments from Bootstrap Bio CEO Chase Denecke or Chief Technology Officer Ben Korpan, but cites an online essay by the two founders about “gene editing adults to make them smarter.”

    It also spoke with Simone and Malcolm Collins, the rightwing pronatalists, about their investment in Bootstrap Bio and whether they would genetically modify their own children. “We’re going to be on that as soon as we can be,” she told Bloomberg News.

    Bootstrap Bio is not alone. In early June, Massachusetts Institute of Technology (MIT) Technology Review reported that Brian Armstrong, the founder of Coinbase whose worth is estimated at $10 billion, had just posted on X that he is “ready to fund a US startup focused on gene-editing human embryos” and is “looking for gene-editing scientists and bioinformatics specialists to form a founding team” for the effort.

    “I think the time is right for the defining company in the US to be built in this area,” Armstrong posted.

    Writing on his X account in April, he predicted that the “IVF [in-vitro fertilization] clinic of the future will combine a handful of technologies” — embryo editing, lab-made eggs, artificial wombs and polygenic testing of thousands of IVF embryos — which he terms “the Gattaca stack.”

    This is not Armstrong’s first venture that seeks to commercialize human biotechnologies; he is an investor in the controversial embryo-testing company Orchid (as is Anne Wojcicki, the co-founder and CEO of the now-bankrupt 23andMe)…..”

    https://childrenshealthdefense.org/defender/tech-billionaires-spearhead-efforts-gene-edited-designer-babies/

    Liked by 1 person

  11. “Courts banned this herbicide twice. The EPA wants to bring it back.

    By Amudalat Ajasa, The Washington Post

    (iStock / Getty Images Plus)

    EXCERPT: “The Environmental Protection Agency announced Wednesday its proposed decision to reregister dicamba, a herbicide widely used on soybean and cotton farms that has been banned twice by federal courts. The EPA originally approved dicamba’s use on genetically engineered soybeans and cotton in 2016.

    Environmental groups sued the EPA over dicamba in 2020 because of its potential drift away from the intended target, especially during warmer temperatures, and harm neighboring crops, nearby ecosystems and rural communities.

    The U.S. Court of Appeals for the 9th Circuit ruled against the EPA and said the agency “understated the amount of dicamba damage.” The court determined that dicamba “caused substantial and undisputed damage” that tore the “social fabric of the farming communities.”

    After the court vacated the herbicide’s registration, the EPA re-registered it months later, and was again challenged by environmental groups. A second federal court vacated that registration in 2024 and prohibited the sale of the herbicide.

    In its new proposal, the EPA said it would address risks from dicamba’s volatility by requiring temperature cut offs above 95 degrees and the increased use of drift reduction agents when temperatures are above 75 degrees. It also includes plans to address the risk of runoff. The proposed mitigations will “minimize impact to certain species and the environment,” said EPA spokesperson Molly Vaseliou in a statement. Agriculture groups applauded the EPA’s proposal.

    The American Soybean Association, a trade association, said in a statement that dicamba is a critical tool for soybean farmers.

    “While ASA is still reviewing the details of EPA’s long-anticipated proposed re-registration decision, we recognize the agency has conducted a robust scientific assessment to evaluate and address potential risks associated with over-the-top dicamba use,” the statement said.

    The proposed registration includes products containing dicamba made by Bayer, Syngenta, and BASF…..”

    https://www.adn.com/nation-world/2025/07/23/courts-banned-this-herbicide-twice-the-epa-wants-to-bring-it-back/

    Liked by 1 person

  12. they’re screwing POTUS again…time to go nuclear on their asses!!

    Liked by 1 person

Comments are closed.